Communicable Disease Control Manual

​The Communicable Disease Control manual includes guidelines on recommended practices for the follow-up of selected communicable diseases, and is intended for use by public health professionals in Saskatchewan. Please refer to the disclaimer as it provides other references that should be consulted in conjunction with this manual.

​Section Title ​Section Number ​Date Completed
General Information
​​Introduction
Prevention and Control of Communicable Diseases
Roles of the Stakeholder
The Chain of Infection
Section 1
1-10
1-20
1-30
1-40

May 2010
May 2010
May 2010
May 2010
Respiratory and Direct Contact
Introduction and General Considerations
Diphtheria
Group A Streptococcal Disease (invasive)
Haemophilus influenzae
Influenza
Legionellosis
Leprosy (Hansen's Disease)
Measles
Meningococcal Disease (invasive)
Mumps
Neonatal Group B Streptococcus
Pertussis
Pneumococcal Disease (invasive)
Rubella
Congenital Rubella Syndrome/Infection (CRS/CRI)
Severe Respiratory Illness (SRI)
Varicella (Chickenpox)
Section 2
2-10
2-30
2-40
2-50
2-60
2-70
2-80
2-90
2-100
2-110
2-120
2-140
2-150
2-160
2-165
2-170
2-210

Oct 2010
Oct 2010
Mar 2011
Jun 2012
Aug 2011
Feb 2011
Feb 2011
May 2014
May 2015
Oct 2011
Aug 2011
Aug 2011
Feb 2011
Aug 2011
Aug 2011
Jan 2015
Feb 2011
Enteric Illness
Introduction and General Considerations
Amoebiasis
Botulism
Campylobacteriosis
Cryptosporidiosis
Cyclosporiasis
Escherichia coli (verotoxigenic)
Giardiasis
Hepatitis A
Listeriosis
Salmonellosis
Shigellosis
Trichinosis
Typhoid Fever
Yersiniosis
Section 3
3-10
3-30
3-50
3-60
3-80
3-90
3-100
3-120
3-110
3-130
3-170
3-180
3-190
3-200
3-210

Jun 2012
Jun 2012
Jun 2012
Mar 2012
Mar 2012
Jun 2012
Oct 2012
Jun 2015
Jun 2015
Mar 2012
Dec 2012
Apr 2014
Mar 2012
Jun 2015
Mar 2012
Vector-Borne and Zoonotic Diseases
Hantavirus Infections
Lyme Disease
Rabies
West Nile Virus
Section 4
4-50
4-70
4-110
4-150

Apr 2014
Jul 2012
May 2015
Jul 2014
Sexually Transmitted Infections
Introduction and General Considerations
Chlamydia
Gonococcal Infections
Lymphogranuloma Venereum (LGV)
Syphilis
Section 5
5-10
5-20
5-30
5-60
5-70

Jul 2010
Jan 2012
May 2015
Jul 2010
Aug 2014
Blood and Body Fluid Pathogens
Hepatitis B
Hepatitis C
Human Immunodeficiency Virus (HIV)
​Section 6
6-20
6-30
6-40

Jun 2014
Jun 2014
Oct 2015
Other
Head Lice
Section 7
7-20

​Nov 2010
​Antibiotic Resistant Organisms/Antibiotic Associated Organisms (ARO/AAO)Section 8
Outbreaks
Outbreaks in LTC and Integrated Facilities
Generic Protocols
Generic Respiratory Protocol
Generic Enteric Protocol
Antiviral Use for Influenza Outbreaks in Special Care Homes
​Section 9

9-30
9-40
9-50
9-60


​Jun 2010
Jun 2010
Jun 2010
Oct 2016
Documentation
Introduction
How to Create/Maintain Client
How to Merge Clients
How to Create/Maintain A CD Case
How to Create/Maintain an STI Encounter
How to Create/Maintain Laboratory Information
How to Enter Animal Exposures
Section 10
10-10
10-20
10-23
10-30
10-40
10-50
10-60

May 2016
June 2016
June 2016
May 2016
May 2016
May 2016
August 2010
Appendixes
Reporting and Follow-up Timelines
Publicly Funded Medications for Chemoprophylaxis/Treatment
Contact Information for RHAs, FNIH and NITHA
Patient Information Sheet
Notification to Canadian Blood Services
Notification to Occupational Health and Safety
Notification to Saskatchewan Transplant Program

​Appendix A
Appendix D
Appendix E
Appendix F
Appendix K
Appendix L
Appendix M

​Nov 2012
Jan 2015
Oct 2010
May 2015
Jan 2015
Apr 2014
Jan 2015

 

Selected Attachments as Templates or Forms

All attachments are included in pdf version in their associated sections/chapters. These selected attachments are provided as:

  • a form that can be downloaded to complete electronically for submission to the Ministry of Health, or
  • a template that is intended for public health officials to use once they have incorporated local details.

Respiratory and Direct Contact - Section 2
Diphtheria Case Investigation Worksheet - Section 2-30
Diphtheria Contact Investigation Worksheet - Section 2-30
Diphtheria Template Letter to Parents - Section 2-30
Invasive Group A Streptococcal Disease Investigation Form - Section 2-40
Haemophilus Influenzae Type B Case Investigation Worksheet - Section 2-50
Haemophilus Influenzae Type B Invasive Disease-Prophylaxis Recommended Sample Letter -Section 2-50
Haemophilus Influenzae Type B Invasive Disease-Prophylaxis NOT Recommended Sample Letter -Section 2-50
Community Influenza-like Illness Weekly Surveillance Form - Section 2-60
Letter to a Measles Case - Section 2-90
Letter to a Measles Contact - Section 2-90
Letter to a School or Group Exposed to a Measles Case - Section 2-90
Measles IG Release Control Form - Section 2-90
Severe Acute Respiratory Illness - SARI - Screening Tool - Section 2-170

Vector-Borne and Zoonotic Diseases - Section 4
Hantavirus Pulmonary Syndrome Case Report Form - Section 4-50
Animal Bite Investigation Form - Section 4-110
Animal Bite Investigation Form - PDF
WNV Physician Reporting Form - Section 4-150

Sexually Transmitted Infections - Section 5
Sexually Transmitted Infections Notification Form - fillable PDF
Sexually Transmitted Infections Notification Form - PDF

Blood and Body Fluid Pathogens - Section 6
HIV Case Reporting Form - PDF
AIDS Case Report Form - PDF

Outbreaks - Section 9
Long Term Care Respiratory Outbreak Infection Control Measures Sample Checklist - Section 9-40
Long Term Care Enteric Outbreak Infection Control Measures Sample Checklist - Section 9-50
Outbreak Notification Report and Summary Form - Section 9-55
Tamiflu Approval for Influenza Outbreak Form - Section 9-60